Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 347 |
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 3 | 3 | 4 | 12 | 18 | 11 | 0 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 575 |
| Views | |
|---|---|
| Argentina | 81 |
| United States | 62 |
| Peru | 29 |
| Mexico | 25 |
| Spain | 16 |
| Colombia | 13 |
| Ecuador | 10 |
| Chile | 9 |
| Canada | 8 |
| Cuba | 8 |
| Views | |
|---|---|
| Buenos Aires | 20 |
| Lima | 17 |
| Mexico | 11 |
| Quito | 8 |
| San Diego | 7 |
| Vancouver | 7 |
| Federal | 6 |
| Menlo Park | 6 |
| La Habana | 5 |
| La Paz | 5 |